Pinion John Richard
See Remarks
Pinion John Richard has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Apr 20, 2026.
On the most recent filing, Pinion John Richard is listed as See Remarks at Ultragenyx Pharmaceutical Inc. Inside the rolling window, Pinion John Richard reported no open-market purchases and 1 open-market sale totaling $229K in RARE.
Companies traded
Other insiders at RARE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$229K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pinion John Richard made?
Pinion John Richard has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Pinion John Richard trade?
Pinion John Richard has filed SEC Form 4 disclosures for 1 company, including RARE.
When was Pinion John Richard's most recent SEC Form 4 filing?
Pinion John Richard's most recent SEC Form 4 filing on Tracefour is dated Apr 20, 2026.
What is Pinion John Richard's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Pinion John Richard is listed as See Remarks.
What is Pinion John Richard's total buy and sell value in the current window?
Inside the rolling retention window, Pinion John Richard bought $0 and sold $229K based on SEC Form 4 filings.
What was Pinion John Richard's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,029 RARE shares on 2026-03-02, worth $229K, per SEC Form 4 filings.